ARF1, ADP ribosylation factor 1, 375

N. diseases: 61; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0241654
Disease: Abnormal heart valve morphology
Abnormal heart valve morphology
0.100 Biomarker phenotype HPO
CUI: C0410702
Disease: Adolescent idiopathic scoliosis
Adolescent idiopathic scoliosis
0.100 GeneticVariation disease GWASCAT Genome-wide association study identifies 14 previously unreported susceptibility loci for adolescent idiopathic scoliosis in Japanese. 31417091 2019
CUI: C2347747
Disease: Adult Classical Hodgkin Lymphoma
Adult Classical Hodgkin Lymphoma
0.010 Biomarker disease BEFREE BFA induced disruption of the Golgi apparatus in ALK+ ALCL cell lines, which was accompanied by a decrease in active ADP-ribosylation factor 1 (ARF1), whereas BFA had no significant effect on these parameters in HL cell lines. 26105086 2015
CUI: C0278878
Disease: Adult Glioblastoma
Adult Glioblastoma
0.010 PosttranslationalModification disease BEFREE Finally, we found that EGFR gene amplifications were associated with distinct tumor infiltration patterns, thus representing a putative novel functional association between EGFR gene amplification and ARF1 gene promoter methylation in GB. 28631186 2017
CUI: C0003486
Disease: Aortic Aneurysm
Aortic Aneurysm
0.100 Biomarker disease HPO
CUI: C0003504
Disease: Aortic Valve Insufficiency
Aortic Valve Insufficiency
0.100 Biomarker disease HPO
Attention deficit hyperactivity disorder
0.100 Biomarker disease HPO
CUI: C3642347
Disease: Basal-Like Breast Carcinoma
Basal-Like Breast Carcinoma
0.010 Biomarker disease BEFREE We demonstrate that ARF1 can be found in complex with Grb2 and p66Shc upon EGF stimulation of the basal-like breast cancer MDA-MB-231 cell line. 24407288 2014
CUI: C1458140
Disease: Bleeding tendency
Bleeding tendency
0.100 Biomarker phenotype HPO
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.320 Biomarker disease CTD_human These findings underline the importance of ARF1 in promoting metastasis and suggest that LM11 that inhibits ARF1 activation may represent a potential therapeutic approach to prevent or treat breast cancer metastasis. 27517156 2016
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.320 Biomarker disease BEFREE In conclusion, this study provides a new mechanism by which ARF1 regulates cell migration and identifies this GTPase as a promising pharmacological target to reduce metastasis formation in breast cancer patients. 23707487 2013
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.320 Biomarker disease BEFREE These findings underline the importance of ARF1 in promoting metastasis and suggest that LM11 that inhibits ARF1 activation may represent a potential therapeutic approach to prevent or treat breast cancer metastasis. 27517156 2016
CUI: C0206695
Disease: Carcinoma, Neuroendocrine
Carcinoma, Neuroendocrine
0.010 Biomarker disease BEFREE In summary, our data indicate an important regulatory role for Arf1 at the Golgi in hypersecretion in neuroendocrine cancer cells. 25754106 2015
CUI: C4048328
Disease: cervical cancer
cervical cancer
0.010 Biomarker disease BEFREE LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis. 31232491 2020
CUI: C0302592
Disease: Cervix carcinoma
Cervix carcinoma
0.010 Biomarker disease BEFREE LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis. 31232491 2020
CUI: C0280474
Disease: Childhood Glioblastoma
Childhood Glioblastoma
0.010 PosttranslationalModification disease BEFREE Finally, we found that EGFR gene amplifications were associated with distinct tumor infiltration patterns, thus representing a putative novel functional association between EGFR gene amplification and ARF1 gene promoter methylation in GB. 28631186 2017
CUI: C1333064
Disease: Classical Hodgkin's Lymphoma
Classical Hodgkin's Lymphoma
0.010 Biomarker disease BEFREE BFA induced disruption of the Golgi apparatus in ALK+ ALCL cell lines, which was accompanied by a decrease in active ADP-ribosylation factor 1 (ARF1), whereas BFA had no significant effect on these parameters in HL cell lines. 26105086 2015
CUI: C0085109
Disease: Corneal Neovascularization
Corneal Neovascularization
0.010 Biomarker disease BEFREE Compared with vehicle-treated mice, ARF1 inhibitor-treated mice exhibited impaired CNV 3 weeks after injury, as evidenced by corneal whole mount CD31-staining. 23288987 2012
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.010 AlteredExpression disease BEFREE We also examined Arf1 expression in the brain of CJD patients with the subtypes MM1 and VV2 and found that it was regulated in a region-specific manner. 25896910 2015
CUI: C0274306
Disease: Cutaneous anaphylaxis
Cutaneous anaphylaxis
0.010 Biomarker disease BEFREE Furthermore, we show that ARF1 peptide inhibits IgE-mediated passive cutaneous anaphylaxis reaction. 30472514 2019
CUI: C1277241
Disease: Delayed myelination
Delayed myelination
0.100 Biomarker phenotype HPO
Delayed speech and language development
0.100 Biomarker phenotype HPO
CUI: C0014378
Disease: Enterovirus Infections
Enterovirus Infections
0.010 Biomarker group BEFREE Enterovirus 3A was previously also proposed to recruit PI4KIIIβ via GBF1/Arf1, based on the known interaction of 3A with GBF1, an important regulator of secretory pathway transport and a guanine nucleotide exchange factor (GEF) of Arf1. 24352456 2014
CUI: C0017168
Disease: Gastroesophageal reflux disease
Gastroesophageal reflux disease
0.100 Biomarker disease HPO
CUI: C0017636
Disease: Glioblastoma
Glioblastoma
0.010 PosttranslationalModification disease BEFREE Finally, we found that EGFR gene amplifications were associated with distinct tumor infiltration patterns, thus representing a putative novel functional association between EGFR gene amplification and ARF1 gene promoter methylation in GB. 28631186 2017